Skip to main content
Clinical Trials/NCT03930355
NCT03930355
Completed
Not Applicable

Effect of Perioperative Transfusion on Early and Late Outcome After Major Elective Surgery

Diskapi Teaching and Research Hospital60 sites in 1 country6,121 target enrollmentMay 1, 2019

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Blood Transfusion
Sponsor
Diskapi Teaching and Research Hospital
Enrollment
6121
Locations
60
Primary Endpoint
Acute kidney injury
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

A secondary analysis of the Turkish National Perioperative Transfusion Study (TULIP TS) database will be performed.

Detailed Description

The Turkish National Perioperative Transfusion Study (TULIP TS) was conducted by The Turkish Society of Anesthesiologists' Multicentre Clinical Trials Network. TULIP TS included 6481 patients undergoing major elective surgery, from 61 study sites across the country. Transfusion practices of clinicians working at diverse surgical fields; differences between current transfusion practices and patient blood management strategies; the areas for improvement and the obstacles that could prevent change were evaluated and identified. Data relevant to perioperative transfusion rates of red blood cells, fresh frozen plasma and platelets, the indications for transfusion and postoperative adverse outcomes including 1 month all cause mortality was obtained. The TULIP TS group aims to collect further data concerning 1 year all cause mortality of the same patient population and to evaluate adverse outcomes in transfused and non transfused patients.

Registry
clinicaltrials.gov
Start Date
May 1, 2019
End Date
December 30, 2020
Last Updated
4 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

DILEK YAZICIOGLU

Assoc Prof

Diskapi Teaching and Research Hospital

Eligibility Criteria

Inclusion Criteria

  • Patients undergoing major elective surgery

Exclusion Criteria

  • Trauma patients, emergency surgery

Outcomes

Primary Outcomes

Acute kidney injury

Time Frame: postoperative 30th day

Number of participants with acute kidney injury

Thromboembolic event

Time Frame: postoperative 30th day

Number of participants with a thromboembolic event

Infection

Time Frame: postoperative 30th day

Number of participants with infection

1 year all cause mortality

Time Frame: postoperative 366th day

Number of participants died: all cause mortality

Acute respiratory failure

Time Frame: postoperative 30th day

Number of participants with acute respiratory failure

Ischemic event

Time Frame: postoperative 30th day

Number of participants with an ischemic event

Myocardial infarction

Time Frame: postoperative 30th day

Number of participants with myocardial infarction

Adverse cardiac event

Time Frame: postoperative 30th day

Number of participants with an adverse cardiac event

Study Sites (60)

Loading locations...

Similar Trials